Wellbutrin and Bupropion: A Unique Antidepressant With Multiple Clinical Applications

Bupropion, sold under brand names including Wellbutrin for depression and Zyban for smoking cessation, is an atypical antidepressant that differs mechanistically from SSRIs, SNRIs, and tricyclics. It works primarily by inhibiting the reuptake of dopamine and norepinephrine rather than serotonin, making it the most prominent norepinephrine-dopamine reuptake inhibitor, or NDRI, in clinical use. This distinct mechanism produces a clinical profile that differs meaningfully from serotonergic antidepressants. Because bupropion has minimal or no effect on serotonin reuptake, it is one of the few antidepressants that does not commonly cause sexual side effects. For patients whose quality of life is significantly affected by sexual dysfunction from other antidepressants, switching to bupropion or adding it to an existing regimen is a well-established clinical approach. Major depressive disorder is the primary FDA-approved indication for the Wellbutrin forms of bupropion. Clinical efficacy data support its use as first-line monotherapy for depression, and it is commonly prescribed when the preferred antidepressant profile includes less weight gain, less sexual dysfunction, and more energizing qualities compared to SSRIs. Seasonal affective disorder, a pattern of recurring depression associated with reduced light exposure in winter months, has its own FDA approval for extended-release bupropion. Patients with SAD may take bupropion prophylactically beginning in autumn before the seasonal mood decline typically begins. Smoking cessation represents another distinct indication. Zyban-labeled bupropion was the first non-nicotine prescription aid for smoking cessation approved in the United States. It reduces nicotine cravings through its dopaminergic activity and general reduction of withdrawal-related dysphoria. Prescribers sometimes use the antidepressant formulation for this indication off-label as well. The activating quality of bupropion makes it particularly useful for patients with fatigue, low energy, and hypersomnia as prominent depression features. However, this same quality means insomnia and agitation are among its more common side effects, particularly during initiation. Seizure risk, which is dose-dependent, is the most serious safety consideration with bupropion. For patients exploring bupropion as a treatment option, learning about wellbutrin-bupropion for depression management provides a comprehensive overview. For patients comparing bupropion to SSRIs and other antidepressant classes, the resources at antidepressant medication category guides offer valuable context.